Patents by Inventor Abdulsalam SHAABAN

Abdulsalam SHAABAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BINDING MOLECULES FOR THE TREATMENT OF CANCER
    Publication number: 20240150480
    Abstract: This invention relates to binding molecules that bind specifically to TNF-related apoptosis-inducing ligand receptor 2 (TRAILR2) and cadherin-17 (CDH17) and their use in medicine, pharmaceutical compositions comprising the same, and methods of using the same as agents for treatment and/or prevention of cancer.
    Type: Application
    Filed: November 14, 2023
    Publication date: May 9, 2024
    Inventors: Klaus-Peter KUENKELE, Timothy FENN, Juan Manuel GARCIA-MARTINEZ, Jason HO, Christian KOESSL, Saurabh SEN, Vladimir VOYNOV, Andreas WERNITZNIG, Ertan ERYILMAZ, Rajkumar GANESAN, Abdulsalam SHAABAN
  • Novel Tri-specific Binding Molecules
    Publication number: 20220411533
    Abstract: The present invention relates to novel tri-specific binding molecules. The invention also relates to nucleic acids encoding such binding molecules; to methods for preparing such binding molecules; to host cells expressing or capable of expressing such binding molecules; to compositions comprising such binding molecules; and to uses of such binding molecules or such compositions, in particular for therapeutic purposes in the field of cancer diseases.
    Type: Application
    Filed: June 15, 2022
    Publication date: December 29, 2022
    Inventors: Paul ADAM, Stephen R. COMEAU, Philip Nicholas GORMAN, Pankaj Gupta, Priyanka GUPTA, Karl-Heinz HEIDER, Srinath KASTURIRANGAN, Renate KONOPITZKY, Klaus-Peter KUENKELE, Sandeep KUMAR, Taneisha Ann-Tanara MACK, Elinborg Katrin OSTERMANN, Abdulsalam SHAABAN, David WEISMANN, Andreas WERNITZNIG, David S. YOUNG
  • ANTI-PD-1 ANTIBODIES
    Publication number: 20210380696
    Abstract: The present invention relates to new anti-PD-1 (Programmed cell death 1) antibodies and antigen-binding fragments thereof for therapeutic and diagnostic methods and compositions using them.
    Type: Application
    Filed: May 24, 2021
    Publication date: December 9, 2021
    Inventors: David A. BLAIR, Nicole K. GARAFFA, Pankaj GUPTA, Priyanka GUPTA, Fei HAN, Aaron Timothy KARLAK, Dongmei LIU, Ivo LORENZ, Mouhamadou Lamine MBOW, Miguel E. MORENO-GARCIA, Joseph A. MOZDZIERZ, Kerry L.M. RALPH, Abdulsalam SHAABAN, Della M. WHITE, Helen Haixia WU, Guangwei YANG
  • Engineered Erythroid Cells Including HLA-G Polypeptides and Methods of Use Thereof
    Publication number: 20210246426
    Abstract: The present disclosure relates to engineered erythroid cells and enucleated cells that include one or more of exogenous HLA-G polypeptides, exogenous immunogenic polypeptides, and exogenous coinhibitory polypeptides wherein the cells are capable of inducing immune tolerance and/or reducing immune response to the exogenous immunogenic polypeptides when administered to a subject.
    Type: Application
    Filed: June 1, 2020
    Publication date: August 12, 2021
    Applicant: Rubius Therapeutics, Inc.
    Inventors: Regina Sophia Salvat, Christopher Lawrence Moore, Abdulsalam Shaaban
  • BINDING MOLECULES FOR THE TREATMENT OF CANCER
    Publication number: 20210095038
    Abstract: This invention relates to binding molecules that bind specifically to TNF-related apoptosis-inducing ligand receptor 2 (TRAILR2) and cadherin-17 (CDH17) and their use in medicine, pharmaceutical compositions comprising the same, and methods of using the same as agents for treatment and/or prevention of cancer.
    Type: Application
    Filed: October 30, 2020
    Publication date: April 1, 2021
    Inventors: Klaus-Peter KUENKELE, Timothy FENN, Juan Manuel GARCIA-MARTINEZ, Jason HO, Christian KOESSL, Saurabh SEN, Vladimir VOYNOV, Andreas WERNITZNIG, Ertan ERYILMAZ, Rajkumar GANESAN, Abdulsalam SHAABAN
  • MULTI-SPECIFIC BINDING PROTEINS
    Publication number: 20170002097
    Abstract: This invention generally relates to multi-specific binding proteins. The invention also relates to methods of making such proteins and to methods of using such proteins. Pharmaceutical compositions and kits comprising such proteins are also disclosed.
    Type: Application
    Filed: June 29, 2016
    Publication date: January 5, 2017
    Inventors: Rajkumar GANESAN, Sanjaya SINGH, Abdulsalam SHAABAN